UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): July 23, 2010
ORTHOVITA, INC.
(Exact Name of Registrant Specified in Charter)
| | | | |
| Pennsylvania | | 0-24517 | | 23-2694857 |
(State or Other Jurisdiction of Incorporation) | | (Commission File Number) | | (IRS Employer Identification No.) |
| | |
77 Great Valley Parkway Malvern, Pennsylvania | | 19355 |
| (Address of Principal Executive Offices) | | (Zip Code) |
Registrant’s telephone, including area code: (610) 640-1775
(Former Name and Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the Registrant under any of the following provisions:
| ¨ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
| Item 5.07 | Submission of Matters to a Vote of Security Holders |
At the 2010 Annual Meeting of Shareholders of Orthovita, Inc. (the “Company”) held on July 26, 2010 in Philadelphia, Pennsylvania, the Company’s shareholders voted on the following matters:
| (a) | Election of seven directors to serve on the Board of Directors of the Company until the next annual meeting of shareholders or until their respective successors have been properly elected or appointed: |
| | | | | | |
Director | | Votes
For | | Votes
Withheld | | Broker
Non-Votes |
R. Scott Barry | | 53,817,753 | | 90,842 | | 11,559,806 |
Morris Cheston, Jr. | | 53,089,338 | | 819,257 | | 11,559,806 |
Antony Koblish | | 51,487,884 | | 1,134,711 | | 12,845,806 |
Mary E. Paetzold | | 53,818,353 | | 90,242 | | 11,559,806 |
Paul G. Thomas | | 53,882,717 | | 85,878 | | 11,559,806 |
William E. Tidmore, Jr. | | 52,393,669 | | 1,514,926 | | 11,559,806 |
Paul Touhey | | 52,389,747 | | 1,518,848 | | 11,559,806 |
| | | | | | | | |
| | | Votes For | | Votes Against | | Abstain | | Broker
Non-Votes |
(b) Ratification of the appointment of KPMG LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2010 | | 65,265,793 | | 192,769 | | 9,835 | | 4 |
The foregoing votes reflect that all director nominees were elected and that KPMG LLP was ratified as the Company’s independent registered public accounting firm for the year ending December 31, 2010.
On July 23, 2010, the U.S. Food and Drug Administration granted premarket approval for the Company’s new collagen processing facility in Malvern, Pennsylvania. The Company will use the new facility to process the highly purified form of collagen used in its VITAGEL™ Surgical Hemostat product. A copy of the press release announcing this approval is included as Exhibit 99.1 to this report.
| Item 9.01 | Financial Statements and Exhibits |
(d) Exhibits
| | |
Exhibit
No. | | Description |
| |
| 99.1 | | Press Release, dated July 26, 2010, issued by Orthovita, Inc. |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| | |
| ORTHOVITA, INC. |
| |
| By: | | /S/ CHRISTINE J. ARASIN |
| | Vice President and General Counsel |
Dated: July 28, 2010
